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Malignant diseases are the second cause of death after car-
diovascular pathology. The level of the breast cancer inci-
dence in Latvia is similar to that in the European Union
member states as well the United States, China and Japan
(Ferlay et al., 2013). In recent decades, there has been a
high prevalence of risk factors in the female population,
such as anthropometric factors (increase of body mass and
obesity, low physical activity) (Vander et al., 2012), harm-
ful habits (tobacco-use etc.), inadequate dietary habits (low
fruit and vegetable intake), various manipulations (injec-
tions, hormonal replacement therapy) (Majeed et al., 2014).
The growth of obesity and physical inactivity of the popula-
tion is associated to breast cancer in more than 30% of cases
in Western Europe (Matthews et al., 2016; Godinho-Mota
et al., 2018). The adiposity of oncological patients develops
as a response to the combination of the generalised inflam-
mation syndrome and dominance of catabolic processes in
muscular tissue due to low physical activity level (Ceder-
holm et al., 2017), as well as fat-infiltrates in muscular tis-
sues causing decrease of muscular tissue functional capaci-
ties (Cruz-Jentoft et al., 2019). Obesity is an important risk
factor of oncological pathology (the breast cancer) and
causes high mortality of patients in the postmenopausal
women group. Adiposity has a harmful effect on differential
stage of a malignant tumour, its size, angio-lymphatic inva-
sion and lymph node involvement in metastatic process.
The combination of adiposity and breast cancer results in
increased aggressive characteristics of the tumour and in-
creased rate of mortality (Hilmi et al., 2019). The most
practical and effective approach of adiposity assessment is
the usage of body mass index (BMI), waist circumference
(WC), waist-to-height ratio (WHtR) and the skinfold thick-
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According to a statistical review (2018) in Latvia, there are more than one thousand women (n =
1266) with the diagnosis of breast cancer. Assessments of anthropometrical parameters were
made according to the World Health Organisation recommendations for morbidity risk analysis.
The aim of the study was to determine the differences and changes of anthropometric parameters
and indices in a control group and in a clinical group (initial oncological diagnosis without treat-
ment intervention). We examined women in their postmenopausal period. The control group in-
cluded apparently healthy women (n = 181) and the clinical group included women (n = 44) with
initial oncological diagnosis (breast cancer 1st and 2nd stage). In order to assess body anthro-
pometric characteristics we used the body mass index (BMI), waist circumference, waist/height
ratio and skin fold thickness measurement. The study results were assessed using statistical
analyses in the IBM SPSS Statistics for Windows, Version 22.0 software: Shapiro–Wilk and
Mann–Whitney tests with a two-tailed p-value < 0.05). The analysis of statistical data showed
that, despite the low number of patients in the clinical group, we found a significantly lower waist-
to-hip ratio, skinfold thickness above m. biceps brachii, skinfold thickness above m. triceps bra-
chii, and subscapular and suprailiac skin fold thickness in this group.
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S h o r t C o m m u n i c a t i o n
ness measurement test (Roriz et al., 2017). BMI is com-
monly considered as a valid instrument for identification of
obesity, but may yield a false diagnosis of body fatness
(Shah et al., 2012), especially in young healthy adults (Zac-
cagni et al., 2014). The evaluation of anthropometric data as
risk factors becomes more precise by combine use of BMI
and WC (Wu et al., 2018). Higher incidence of malignant
tumour is associated with the fat distribution type (as a risk
factor) in the upper abdominal region (visceral fat). Ab-
dominal fatness is a high risk factor for oncological pathol-
ogy (without increase of BMI) in the female population. A
Body Shape Index (ABSI) was specifically developed for
evaluation of central obesity. ABSI was found to be supe-
rior to BMI and WC in determining metabolic changes and
disease risks in the general USA population (Krakauer et
al., 2014). Studies in China also found a positive associa-
tion between ABSI and disease risk and mortality (He et al.,
2013). Moreover, ABSI is considered to be a predictor of
total mortality, as found in several cohort observational
studies with follow-ups ranging from 5 to 25 years
(Krakauer et al., 2012). Studies of body composition have
shown that ABSI is positively associated with fat mass and
negatively associated with fat-free mass (Dhana et al.,
2016). The body roundness index (BRI) has been applied as
a new approach in assessment of body fat and visceral adi-
pose tissue volume (Thomas et al., 2013). BRI is used for
risk assessment in clinics to identify diabetes mellitus and
cardiovascular health status (Chang et al., 2015). One of the
most effective indicators of cardiovascular diseases is the
conicity index (CI), an indicator of abdominal adiposity,
which is used as instrument for assessment of body fat dis-
tribution and morbidity risk (de Sousa et al., 2020). The as-
sociation between fat distribution in the body and health
level has been studied (Ehrampoush et al., 2017; Eickem-
berg et al., 2020). WHR was used as a specific indicator for
increased health risk assessment for the middle-aged popu-
lation in a longitudinal study of cardiovascular disease and
mortality (Quaye et al., 2019). The classic anthropometric
method — the skinfold thickness measurement test (SFT)
— was used to determine body composition and body fat
percentage. Increased risk of breast cancer in post-meno-
pausal women is associated with obesity. Analysis of body
composition had importance for oncological patients, as it
allowed to start treatment activities and maintain long-life
quality (Brown et al., 2019).
The study was conducted in Latvia (Rîga) from January
2016 to March 2019. The participants in the control group
were selected randomly from a post-menopausal women
group. The women in the control group (n = 181) were aged
from 40 to 66; the mean age was 53.3 ± 8.3 (SD). The in-
clusion criteria for the control group were lack of oncologi-
cal diseases, diabetes, severe cardiovascular diseases, pul-
monary diseases, neurological diseases, kidneys’ diseases
and gastrointestinal diseases. The patient group consisted of
women (n = 44) aged from 40 to 66 with diagnosed breast
cancer in stage I and stage II; mean age was 55.3 ± 7.7
(SD). Inclusion criteria for the clinical group were initial di-
agnosis of breast cancer (1st or 2nd stage) and no treatment
procedures according to diagnosis. All subjects gave their
informed consent. The Medical Ethics Committee of Rîga
Stradiòð University (Rîga, Latvia, No. 18/28.04.2016) ap-
proved the study protocol for biomedical research. Anthro-
pometric measurements of the women were collected by
specialists of the Anthropological Laboratory of the Insti-
tute of Anatomy and Anthropology, Rîga Stradiòð Univer-
sity.
Weight and height were measured using the Martin R. and
Saller K. method to the nearest 0.1 kg and 0.1 cm, respec-
tively, with the participant in lightweight clothing and with-
out shoes. WC was measured using a tape measure placed
halfway between the lower border of the ribs and the iliac
crest in a horizontal plane at the end of normal expiration
(to the nearest 0.1 cm). The skinfold thickness was meas-
ured precisely at several standardised sites above m. biceps
brachii, above m. triceps brachii. Both the subscapular and
suprailiac skin folds thickness was measured. Indices were
calculated by the following formulas:
Body mass index (BMI) as ratio of weight (kg) and squared
body height (m); Weight Height Ratio (WHtR) as weight
(g) to height (cm) ratio; Body Shape Index (ABSI) was
ABSI
WC
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For statistical analysis, the Shapiro–Wilk test and Mann–
Whitney test with a two-tailed p-value < 0.05 were con-
ducted using IBM SPSS Statistics for Windows, Version
22.0.
Anthropometric characteristics were collected for women in
postmenopausal age divided into clinical and control
groups. The clinical group included women (n = 44) at the
age of 55.30 ± 7.72 years, with the initial diagnosis of
breast cancer, first and second stage, before admitted for
treatment. The control group included healthy women (n =
181), average age 53.25 ± 8.27 years (Table 1).
Assessment of the clinical and control group showed that,
despite different sample sizes in the studied groups, there
were no significant differences in anthropometric character-
istics like height (p = 0.941) and weight (p = 0.941). The
average body height in the clinical group was 163.39 ± 6.24
cm (minimum 145.0 cm; maximum 170.0 cm), and the av-
erage body height for the control group was 163.44 ± 5.93
cm (minimum 159.4 cm, maximum 176.4 cm). The range of
body mass in the clinical study group was 44.8–118 kg, and
in the control from 49.1 kg to 135 kg. There was a tendency
(not significant) of lower body mass in the clinical group
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(mean 73.61 ± 17.45 kg) compared to the control group
(75.30 ± 15.31 kg). The chest circumference (p = 0.0243),
hip circumference (p = 0.895) and waist circumference (p =
0.365) did not significantly differ between respondents of
clinical and control groups. The anthropometric data was
evaluated by combined use of BMI and WC (Wu, et al,
2018). A higher incidence of malignant tumour is associated
with the fat distribution type (as a risk factor) in the upper
abdominal region (visceral fat). There was a lower chest cir-
cumference, waist circumference and hip circumference for
the clinical group, but the differences were not significant
(Table 1). The adiposity assessment was made by using
body mass index (BMI), waist circumference (WC), waist-
to-height ratio (WHtR), and skinfold thickness t (Roriz, et
al., 2017). The mean value of indices such as BMI (p =
0.336), ABSI (p = 0.475), BRI (p = 0.349), CI (p = 0.504)
and WHtR (p = 0.349) did not significantly differ between
clinical and control groups. However, there was a tendency
of lower mean BMI in the clinical group (27.56 ± 6.23,
range 15.0–37.0) than in the control group (28.17 ± 5.49,
range 15.0–45.0). Based on the values of BMI, adiposity
was more common (22.7 % of women) in the clinical group,
than in the control group (12.2% of women). Our data sup-
port the suggestion that adiposity is a risk factor for onco-
logical pathology (breast cancer). Combination of adiposity
and breast cancer diagnosis was observed to be associated
with more aggressive characteristics of tumour and higher
morality rate in a patient group (Hilmi et al., 2019). Over-
weight was observed in 40.9% of women in the clinical
group and in 30.9% respondents of the control group. The
standard value of BMI was observed in 36.4% of women of
the clinical group and 56.9% of women in the control
group. Increased risk of breast cancer in post-menopausal
women is associated with obesity; analysis of body compo-
sition has importance for oncological patients, as it allows
to start treatment and maintain long-life quality (Brown, et
al., 2019). The WHR standard level is 0.67–0.8, according
to the WHO Guidelines (Anonymous, 2016). Higher WHR
over 0.8 is associated with increased health risk (metabolic
disorders, diabetes mellitus, and cardiovascular diseases).
Analysis of the mean WHR (waist to hip ratio) showed sig-
nificant differences (p = 0.055) between clinical and control
groups. Health risk assessment for the middle age popula-
tion can be made using WHR as a specific indicator for car-
diovascular disease and mortality (Quaye et al., 2019). The
average WHR in the clinical group was 0.8 ± 0.07 (range
0.74–0.86), and in the control group 0.83 ± 0.08 (mean
0.7–0.86). The skinfold thickness measurement test (SFT) is
a classic anthropometric method for determining body com-
position and body fat percentage; it is a non-invasive
method of body fat estimation (Rodriguez et al., 2005). The
skinfold thickness is measured precisely at several standard-
ised sites (skinfolds above m. biceps brachii, above m. tri-
ceps brachii, and also subscapular and suprailiac skinfolds
are measured). We found significantly lower skin fold
thickness in the clinical group at the standardised sites
above m. biceps brachii (p = 0.012), above m. triceps bra-
chii (p = 0.011), and at subscapular (p = 0.091) and suprail-
iac (p = 0.031) sites.
Body composition changes can be associated with increased
risk of development oncological pathology — breast cancer.
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Table 1. Age, height, weight, anthropometric indices, and skinfold thickness in the clinical (n = 44) and control (n = 181) groups (women in postmenopausal
period)
Variable Clinical group,
average value and standard deviation
M ± SD
Control group,






Age, years 55.30 ± 7.72 53.25 ± 8.27 6797.0 0.102
Height, cm 163.39 ± 6.24 163.44 ± 5.93 7913.0 0.941
Weight, kg 73.61 ± 17.45 75.30 ± 15.31 7328.5 0.373
Chest circumference, cm 95.40 ± 13.36 98.13 ± 10.82 7129.0 0.243
Waist circumference, cm 86.28 ± 14.47 88.55 ± 14.31 7317.0 0.365
Hip circumference, cm 107.62 ± 14.14 106.79 ± 10.67 7871.5 0.895
Indices
BMI 27.56 ± 6.23 28.17 ± 5.49 7276.5 0.336
WHtR 0.53 ± 0.09 0.54 ± 0.09 7295.0 0.349
WHR 0.80 ± 0.07 0.83 ± 0.08 6592.5 0.055
ABSI 0.0074 ± 0.0004 0.0075 ± 0.0006 7454.0 0.475
BRI 4.07 ± 1.85 4.35 ± 1.95 7295.0 0.349
CI 1.18 ± 0.08 1.20 ± 0.11 7488.0 0.504
Skinfold thickness
M. biceps brachi, mm 8.73 ± 3.39 10.67 ± 4.95 6175.0 0.012
M. triceps brachi, mm 16.16 ± 4.27 18.49 ± 5.81 6150.5 0.011
M. subscapularis, mm 19.71 ± 7.17 21.69 ± 7.63 6756.0 0.091
M. suprailiaca, mm 19.71 ± 7.17 22.62 ± 8.14 6423.5 0.031
Notes: U, Mann–Whitney test value; BMI, body mass index; WHtR, waist-to-height ratio; WHR, waist-to-hip ratio; ABSI, a body shape index; BRI, body
roundness index; CI, conicity index.
The analysis of anthropometric parameters for women in
the postmenopausal age in the clinical group (breast cancer
diagnosis at the first stage and second stage, before treat-
ment) and women in a control group (healthy women) re-
vealed significant differences in the waist-hip index
(WHR), despite different sample sizes. WHR was slightly
lower in the clinical group, as was thickness of the skin fold
over m. triceps brachii, m. biceps brachii, and at subscapu-
lar and suprailiac sites. Comparative analysis of body com-
position in the clinical and control group enriching under-
standing of cancer biology and aetiology.
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ANTROPOMETRISKO PARAMETRU SALÎDZINOÐAIS VÇRTÇJUMS KRÛTS VÇÞA PACIENTÇM UN VESELÂM SIEVIETÇM
POSTMENOPAUZES PERIODÂ
Statistikas dati liecina, ka 2018. gadâ 1266 sievietçm Latvijâ diagnosticçts krûts vçzis. Pçc Pasaules veselîbas organizâcijas rekomendâ-
cijâm antropocentrisko râdîtâju vçrtçjums tiek izmantots onkoloìisko patoloìiju riska novçrtçjumam. Mûsu pçtîjuma mçríis bija noteikt
antropometrisko râdîtâju un indeksu atðíirîbas postmenopauzes vecumâ klîniskajâ grupâ (n = 44) ar agrîna krûts vçþa diagnozi (pirmâ un
otrâ stadija) pirms ârstniecisko pasâkumu sâkuma, un kontroles grupâ (n = 181). Tika noteikti antropometriskie radîjumi (íermeòa garums,
íermeòa masa, apkârtmçri un âdas kroku biezums) un indeksi (íermeòa masas indekss, vidukïa–gurnu indekss, íermeòa masas un auguma
indekss, íermeòa formas indekss, íermeòa apaïuma indekss, íermeòa koniskuma indekss). Iegûto datu statistiskai analîzei tika izmantota
IBM SPSS Statistiskâ programma, 22.0 Versija, Shapiro–Wilk tests, Mann–Whitney tests un noteikta p vçrtîba. Neraugoties uz to, ka bija
skaitliski maza klîniskâ grupa, tika noteiktas statistiski ticamas zemâkas vçrtîbas vidukïa–gurnu indeksam un âdas kroku biezumam virs m.
biceps brachii, m. triceps brachii, kâ arî subskapulârâs un suprailiakâlâs âdas kroku biezumam, salîdzinot ar kontroles grupu.
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